Novavax files for authorisation of Covid-19 shot among adolescents in Britain
Novavax Inc said on Wednesday (May 4) it had filed an application with The Medicines and Healthcare products Regulatory Agency for the authorisation of...
‘Omicron as severe as previous Covid variants’
The Omicron variant of the SARS-CoV2 virus is intrinsically as severe as previous variants, unlike assumptions made in previous studies that it was more...
AstraZeneca sales beat forecasts on Covid jab demand
AstraZeneca on Friday (April 29) beat first-quarter sales and profit expectations, helped by higher than expected sales of its Covid-19 vaccine.
The vaccine recorded $1.15...
Prince Charles hosts a reception for 200 community pharmacists at St James’ Palace in May
His Royal Highness the Prince of Wales is to host a reception at St James’s Palace in early May to celebrate exemplary work of...
Second Global Covid-19 Summit slated for May 12
A second Global Covid-19 Summit will be held virtually next month for countries to discuss efforts to end the pandemic and prepare for future health...
ANALYSIS: Demand for Pfizer’s Covid pills lags around the world
Global demand for Pfizer's oral Covid-19 antiviral treatment Paxlovid has been unexpectedly low due to complicated eligibility requirements, reduced testing, and potential for drug...
Moderna’s Covid shot approved for 6-11 year-olds
Britain's medicines regulator on Thursday approved the use of Moderna 's Covid-19 vaccine in children between 6 and 11 years, as the country bolsters...
UK approves Valneva’s easy-to-store Covid shot
Britain has approved a new coronavirus vaccine by the Austrian-French drugmaker Valneva.
"An approval has been granted after the Valneva Covid-19 vaccine was found to...
WHO tracks two new Omicron sub-variants
The World Health Organization says it is tracking a few dozen cases of two new sub-variants of the highly transmissible Omicron strain of the...
Britain expands access to Pfizer’s oral antiviral Covid-19 treatment through trial
Britain will expand access to Pfizer's oral antiviral Covid-19 treatment to thousands more people by adding it to a trial to assess how best to...
Current Issue March 2024
